Categories: News

NYSE Content Advisory: Pre-Market Update + Seven of the Top 10 IPOs in 2025 List on NYSE

NEW YORK, Dec. 15, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on December 15th

- Advertisement -
  • Stocks are fractionally higher early Monday as a busy week of economic data begins, with non-farm payrolls and retail sales Tuesday, and November CPI Thursday.
  • Seven of the ten largest IPOs of 2025 debuted on the NYSE, including Circle, Figma, and Klarna.
  • NYSE President Lynn Martin said the 2026 priority is “maintaining momentum and simplifying the path for companies to go public while preserving U.S. markets’ reputation as the world’s most trusted, liquid, and competitive.”
  • Baron Capital founder and CEO Ron Baron rings the Opening Bell to celebrate the launch of Baron Active ETFs; tune in to NYSE Live at 9 a.m. ET for his remarks.
  • Dr. Martin Makary joins NewYorkBIO’s Life Science Showcase for a fireside chat on modernizing FDA processes to boost drug development efficiency and U.S. competitiveness.

Opening Bell
Baron Funds celebrates the listings of new ETFs

- Advertisement -

Closing Bell
Equable Shares celebrates the listings of its new ETFs

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2845541/NYSE_Market_Update_Dec_15.mp4 
Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–seven-of-the-top-10-ipos-in-2025-list-on-nyse-302642299.html

- Advertisement -

Recent Posts

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in…

26 minutes ago

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

– Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC…

26 minutes ago

Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings

May 29, 2026 21:18 ET  | Source: Fobi AI Inc. VANCOUVER, BC, May 29, 2026…

7 hours ago

Crypto News Today: AlphaPepe Presale Stage 17 Nears Sell Out While XRP Price Prediction Eyes $7.00

MONACO, May 29, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe as…

7 hours ago